- Home
- IKT vs BKSY Comparison
IKT vs BKSY Comparison
Compare IKT & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- BKSY
- Stock Information
- Founded
- IKT 2008
- BKSY 2013
- Country
- IKT United States
- BKSY United States
- Employees
- IKT N/A
- BKSY N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- BKSY Radio And Television Broadcasting And Communications Equipment
- Sector
- IKT Health Care
- BKSY Technology
- Exchange
- IKT Nasdaq
- BKSY Nasdaq
- Market Cap
- IKT 159.2M
- BKSY 140.9M
- IPO Year
- IKT 2020
- BKSY N/A
- Fundamental
- Price
- IKT $2.96
- BKSY $8.05
- Analyst Decision
- IKT Strong Buy
- BKSY Strong Buy
- Analyst Count
- IKT 2
- BKSY 5
- Target Price
- IKT $6.50
- BKSY $17.60
- AVG Volume (30 Days)
- IKT 354.9K
- BKSY 851.0K
- Earning Date
- IKT 11-12-2024
- BKSY 11-07-2024
- Dividend Yield
- IKT N/A
- BKSY N/A
- EPS Growth
- IKT N/A
- BKSY N/A
- EPS
- IKT N/A
- BKSY N/A
- Revenue
- IKT $79,570.00
- BKSY $107,231,000.00
- Revenue This Year
- IKT N/A
- BKSY $16.72
- Revenue Next Year
- IKT N/A
- BKSY $25.54
- P/E Ratio
- IKT N/A
- BKSY N/A
- Revenue Growth
- IKT N/A
- BKSY 36.77
- 52 Week Low
- IKT $0.80
- BKSY $3.86
- 52 Week High
- IKT $3.82
- BKSY $14.16
- Technical
- Relative Strength Index (RSI)
- IKT 76.96
- BKSY 68.36
- Support Level
- IKT $2.56
- BKSY $6.80
- Resistance Level
- IKT $2.75
- BKSY $6.62
- Average True Range (ATR)
- IKT 0.27
- BKSY 0.56
- MACD
- IKT 0.03
- BKSY 0.16
- Stochastic Oscillator
- IKT 96.43
- BKSY 95.09
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.